Form 4 for PLSE PULSE BIOSCIENCES, INC.
Accepted 2026-02-11 00:00:00 ET · period of report 2026-02-09 · accession 0001437749-26-003840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-11 | 2026-02-09+ | PLSE | Danahy Kevin Patrick | Chief Commercial Off | M - OptEx | $1.53 | +60.0K | 63.3K | +1,819% | +$91.8K |
| DM | 2026-02-11 | 2026-02-09+ | PLSE | Danahy Kevin Patrick | Chief Commercial Off | S - Sale+OE | $23.39 | -60.0K | 43.3K | -58% | -$1.40M |
| DM | 2026-02-11 | 2026-02-09+ | PLSE | Danahy Kevin Patrick | Chief Commercial Off | M - OptEx | $0.00 | -60.0K | 385.0K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-10 | M | A | 20,000 | $1.53 | 63,298 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-09 | M | A | 20,000 | $1.53 | 63,298 | D | — | — | |
| 3 | Common | Common Stock | 2026-02-09 | S | D | 20,000 | $21.45 | 43,298 | D | — | — | (F2) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $21.00 to $23.22 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range. |
| 4 | Common | Common Stock | 2026-02-11 | S | D | 20,000 | $25.20 | 43,298 | D | — | — | (F4) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.36 to $26.36 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range. |
| 5 | Common | Common Stock | 2026-02-10 | S | D | 20,000 | $23.52 | 43,298 | D | — | — | (F3) The price in column 4 is the weighted average price per share sold. The price per share actually received by the reporting person ranged from $23.00 to $26.08 per share. For all transactions reported in this Form 4 using a weighted average price, the reporting person undertakes upon request by the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the range. |
| 6 | Common | Common Stock | 2026-02-11 | M | A | 20,000 | $1.53 | 63,298 | D | — | — | |
| 7 | Derivative | Stock Option (right to buy) | 2026-02-09 | M | D | 20,000 | $0.00 | 405,000 | D | $1.53 · — to 2032-09-23 | 20,000 Common Stock | (F5) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022. |
| 8 | Derivative | Stock Option (right to buy) | 2026-02-11 | M | D | 20,000 | $0.00 | 365,000 | D | $1.53 · — to 2032-09-23 | 20,000 Common Stock | (F5) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022. |
| 9 | Derivative | Stock Option (right to buy) | 2026-02-10 | M | D | 20,000 | $0.00 | 385,000 | D | $1.53 · — to 2032-09-23 | 20,000 Common Stock | (F5) Options granted on September 23, 2022, to acquire up to 450,000 shares of Common Stock, in connection with reporting person's promotion, with 25% vesting on each anniversary of grant, pursuant to the terms of an amendment to reporting person's Employment Agreement dated February 9, 2022. |